Brave Asset Management Inc Crispr Therapeutics Ag Transaction History
Brave Asset Management Inc
- $410 Million
- Q3 2024
A detailed history of Brave Asset Management Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Brave Asset Management Inc holds 7,559 shares of CRSP stock, worth $383,694. This represents 0.09% of its overall portfolio holdings.
Number of Shares
7,559
Previous 700
979.86%
Holding current value
$383,694
Previous $37,000
859.46%
% of portfolio
0.09%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding CRSP
# of Institutions
510Shares Held
57.4MCall Options Held
1.74MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$399 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$381 Million3.35% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$160 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$160 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$141 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.96B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....